The Vanishing Clinical Value of PD-L1 Status as a Predictive Biomarker in the First-Line Treatment of Urothelial Carcinoma of the Bladder
暂无分享,去创建一个
A. Tamalunas | S. Ledderose | L. Unterrainer | C. Stief | S. Rodler | Jozefina Casuscelli | G. Schulz | C. Aydogdu | Melanie Schott